Stockscreener 앱 받기
1.80
5.76%
-0.11
전일 마감가:
$1.91
열려 있는:
$1.89
하루 거래량:
253.34K
Relative Volume:
0.11
시가총액:
$14.22M
수익:
$47.91M
순이익/손실:
$596.30K
주가수익비율:
15.80
EPS:
0.1139
순현금흐름:
$-10.91M
1주 성능:
+1.69%
1개월 성능:
+44.00%
6개월 성능:
+169.38%
1년 성능:
-66.24%
1일 변동 폭
$1.732
$1.9728
1주일 범위
$1.71
$2.08
52주 변동 폭
$0.3403
$5.69
메디롬 헬스케어 테크 Stock (MRM) Company Profile
명칭
Medirom Healthcare Technologies Inc Adr
전화
-
주소
-
MRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRM
Medirom Healthcare Technologies Inc Adr
|
1.80 | 15.09M | 47.91M | 596.30K | -10.91M | 0.1139 |
|
ROL
Rollins Inc
|
56.54 | 27.26B | 3.57B | 489.33M | 631.56M | 1.01 |
|
SCI
Service Corp International
|
79.25 | 11.07B | 4.22B | 530.23M | 639.52M | 3.64 |
|
HRB
H R Block Inc
|
50.35 | 6.71B | 3.71B | 564.15M | 648.29M | 4.08 |
|
BFAM
Bright Horizons Family Solutions Inc
|
118.04 | 6.73B | 2.63B | 116.59M | 215.93M | 1.99 |
|
FTDR
Frontdoor Inc
|
60.75 | 4.40B | 1.83B | 234.00M | 235.00M | 3.03 |
메디롬 헬스케어 테크 주식(MRM)의 최신 뉴스
Medirom’s REMONY: Redefining Transportation Safety Through Health-Centric Innovation - AInvest
Medirom’s 'REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device - The Manila Times
Japan Govt Backs Medirom's 24/7 Driver Fatigue Prevention System with 50% Cost Coverage - Stock Titan
MEDIROM Healthcare Technologies (NYSE:MRM) Shares Up 3.1% – Here’s Why - Defense World
MEDIROM Healthcare Technologies to Integrate World ID Authentication in Relaxation Salons - SSBCrack
MEDIROM to install World ID authentication devices at Re.Ra.Ku salons - Investing.com
MEDIROM adopts cryptocurrency strategy through World partnership - Investing.com
MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World" - GlobeNewswire
500,000 Japanese Users to Access World ID: MEDIROM's Re.Ra.Ku Salons Join Altman's Proof of Human Project - Stock Titan
World partners to deploy biometric orbs in Japan - Biometric Update
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
Medirom Healthcare Surges 79% in Pre-Market Trading After Partnership with Sam Altman-Backed World ID - AInvest
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com UK
Big Moves For Asian Tech Stocks On Wall Street - Finimize
Asian Equities Traded in the US as American Depositary Receipts Advance in Friday Trading - 富途牛牛
ChatGPT Creator's World ID to Deploy AI Human Verification at 500,000 Users Through MEDIROM Partnership - Stock Titan
MEDIROM Healthcare Technologies Inc. (NYSE:MRM) Short Interest Up 88.0% in July - Defense World
MEDIROM Healthcare Technologies Reports Strong June 2025 KPIs - The Globe and Mail
MEDIROM Healthcare Technologies (NYSE:MRM) Trading Down 1.8% – Time to Sell? - Defense World
Medirom Healthcare Stock Dips On Series A Equity Raise: Retail’s Divided - MSN
MEDIROM Approves Stock Options to Drive Growth - The Globe and Mail
Medirom Healthcare Technologies approves new performance-based stock options - Investing.com
WELL Health Technologies (TSE:WELL) Shares Up 3.3% – Time to Buy? - Defense World
MRMForm 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - mx.advfn.com
MEDIROM Healthcare Technologies (NYSE:MRM) Stock Price Up 1% – Here’s What Happened - Defense World
COMPASS SELF STORAGE ANNOUNCES ACQUISITION OF SELF STORAGE CENTER IN WESTERLY, RI - The Manila Times
The Future of Streaming Takes Center Stage at Questex's StreamTV Show 2025 in Denver - The Manila Times
MEDIROM Secures Nasdaq Future: How The Healthcare Company Avoided Delisting Risk - Stock Titan
MEDIROM Healthcare's Subsidiary Achieves Milestone in Health Guidance Services, Reports 21.5% Revenue Growth and 20.1% Net Income Increase. - AInvest
Specific Health Guidance Service Utilizing the 'Lav' Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals! - The Manila Times
Digital Health Success: MEDIROM's Lav App Users Shed 15,421kg While Expanding to 100 Corporate Partners - Stock Titan
United States shares lower at close of trade; Dow Jones Industrial Average down 0.27% - Investing.com India
EnWave Signs License Amendment with Creations Foods to Expand License to Include Pet Treat Applications - The Manila Times
Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures - The Manila Times
MEDIROM Healthcare to Reveal 2024 Performance: Japanese Wellness Tech Leader Hosts Key Investor Webcast - Stock Titan
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting - The Manila Times
MEDIROM Healthcare Technologies (NYSE:MRM) Stock Price Down 4.8% – Should You Sell? - Defense World
Trading Day Review: MEDIROM Healthcare Technologies Inc ADR (MRM) Gains Momentum, Closing at 1.25 - DWinneX
MEDIROM Healthcare Technologies Announces 25th Shareholders Meeting - TipRanks
MEDIROM Healthcare Technologies Inc. Announces March 2022 Key Performance Indicators (KPIs) - The Globe and Mail
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL): Can The Stock Still Lose Despite An -61.39% YTD Loss? - Marketing Sentinel
Major Win: Tetra Tech Secures £36M Smart Water Infrastructure Deal in UK - Stock Titan
US Stock Market: ‘Time for US to stop…’, says China reacting to US market crash - Mint
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
MEDIROM Lands Strategic $2.4M Financing: Mother Bracelet Development Gets Green Light - StockTitan
MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing - The Manila Times
Consolidated Water Reports Full Year 2024 Results - The Manila Times
MEDIROM Mother Labs Hits $60M Valuation as Top Executive Makes Second Strategic Investment - StockTitan
MEDIROM Faces Nasdaq Compliance Challenge - TipRanks
This Groundbreaking Fertility Treatment Could Make IVF ObsoleteNew Presidential Order Accelerates Access - Stock Titan
메디롬 헬스케어 테크 (MRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.44%
2.63%
자본화:
|
볼륨(24시간):